Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells

Brain Research Bulletin

Volumn 51, Issue 5, 2000, Pages 371-378

  Horikoshi, Toru ^a   Naganuma, Hirofumi ^a   Ohashi, Yasuhiro ^a   Ueno, Takehiko ^a   Nukui, Hideaki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Bleomycin; Chemotherapy; Electric stimulation; Glioma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; ETOPOSIDE; NIMUSTINE; VINCRISTINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG POTENTIATION; ELECTRIC FIELD; ELECTROPORATION; ELECTROSTIMULATION; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CARBOPLATIN; CELL DIVISION; ELECTRIC STIMULATION; ETOPOSIDE; GLIOMA; HUMANS; NIMUSTINE; RATS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034009802     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00247-6     Document Type: Article

References (37)

1. Bar-Sella P., Front D., Hardoff R., Peyser E., Borovich B., Nir I. Ultrastructural basis for different pertechnetate uptake patterns by various human brain tumors. J. Neurol. Neurosurg. Psychiatry. 42:1979;924-930.
2. Belehradek J., Orlowski S., Poddevin B., Paoletti C., Mir L.M. Electrochemotherapy of spontaneous mammary tumours in mice. Eur. J. Cancer. 27:1991;73-76.
3. Belehradek J., Orlowski S., Ramirez L., Pron G., Poddevin B., Mir L.M. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochem. Biophys. Acta. 1190:1994;155-163.
4. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek J., Mir L.M. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer. 72:1993;3694-3700.
5. Byrnes R., Petering D. Inhibition of bleomycin-induced cellular DNA strand scission by 1,10-phenanthroline. Biochem. Pharmacol. 41:1991;1241-1248.
6. Ehrenfeld G., Rodrigues O., Hecht S. Copper(I)-bleomycin. Structurally unique complex that mediates oxidative DNA strand scission. Biochemistry. 24:1985;81-92.
7. Feng M.R., Liebert M., Wedemeyer G., Grossman H.B., Mancini W.R., Williams M., Wagner J.G. Effect of verapamil on the uptake and efflux of etoposide (VP16) in both sensitive and resistant cancer cells. Sel. Cancer Ther. 7:1991;75-83.
8. Front D., Even-Sapir E., Israel O., Iosilevsky G., Frenkel A., Milstein D., Epelbaum R., Robinson E., Kolodny G. In vivo measurements of fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumors. Cancer. 67:1991;2477-2483.
9. Front D., Israel O., Even-Sapir E., Iosilevsky G., Frenkel A., Ben-Haim S., Ber R., Robinson E., Kolodny G.M. The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors. Cancer. 64:1989;988-993.
10. Front D., Israel O., Iosilevsky G., Even-Sapir E., Frenkel A., Kolodny G.M., Feinsod M. SPECT quantitation of cobalt-57 bleomycin delivery to human brain tumors. J. Nucl. Med. 29:1988;187-194.
11. Grubler A., Larsson R., Nygren P., Bjorkholm M., Peterson C. A non-P glycoprotein mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells. Leukemia. 8:1994;985-989.
12. Heller R., Jaroszeski M., Leo-Messina J., Perrot R., Voorhis N., Reintgen D., Gilbert R. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem. Bioenerg. 36:1995;83-87.
13. Hofmann, G. Cells in electric fields. Physical and practical electronic aspects of electro cell fusion and electroporation. In: Neumann, E.; Sowers, A.; Jordan, C., eds. Electroporation and electrofusion in cell biology. New York: Plenum Publishing Corp.; 1989:389-406.
14. Inamura T., Black K. Bradykinin selectively open blood-tumor barrier in experimental brain tumors. J. Cereb. Blood Flow Metab. 14:1994;862-870.
15. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma, in vivo. Nippon Gan. Chiryo. Gakkai. Shi. 25:1990;2640-2648.
16. Kénani A., Bailly C., Houssin R., Henichart J. Comparative subcellular distribution of the copper complexes of bleomycin-A2 and deglycobleomycin-A2. Anticancer Drugs. 5:1994;199-201.
17. Krishnamachary N., Center M. The MRP gene associated with a non-P glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
18. Lazo J., Schisselbauer J., Meandzija B., Kennedy K. Initial single strand DNA damage and cellular pharmacokinetics of bleomycin A2. Biochem. Pharmacol. 66:1989;524-531.
19. Levin V., Landahl H., Dove M. The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood brain barrier. J. Pharmacokinet. Biopharm. 4:1976;499-519.
20. Mir L.M., Orlowski S., Belehradek J., Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:1991;68-72.
21. Mir L.M., Orlowski S., Belehradek J., Teissie J., Rols M., Sersa G., Miklavcic D., Gilbert R., Heller R. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem. Bioenerg. 38:1995;203-207.
22. Naganuma H., Sasaki A., Nukui H., Tasaka K. Antiproliferative cytokines secreted by lymphokine activated killer cells stimulated with tumor cells. J. Neurosurg. 77:1992;411-416.
23. Naganuma H., Sasaki A., Satoh E., Sakihama T., Tasaka K., Nukui H. Improved bioassay for the detection of transforming growth factor-b1 and b2 in malignant gliomas. Neurol. Med. Chir. (Tokyo). 34:1994;143-149.
24. Neuwelt E., Specht H., Hill S. Permeability of human brain tumor to 99mTc-gluco-heptonate and 99mTc-albumin. J. Neurosurg. 65:1986;194-198.
25. Ogasawara H., Uozumi T., Kiya K., Kurisu K., Mikami T., Hotta T., Sugiyama K. Analysis and distribution of etoposide in rat brain tumor model Intracarotid versus intracarotid with angiotensin II-induced hypertension. Cancer Invest. 11:1993;299-305.
26. Okino M., Tomie H., Kanesada H., Marumoto M., Esato K., Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. J. Cancer Res. 83:1992;1095-1101.
27. Orlowski S., Belehradek J., Paoletti C., Mir L.M. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37:1988;4727-4733.
28. Poddevin B., Orlowski S., Belehradek J., Mir L.M. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42:1991;567-575.
29. Prausnitz M., Bose V., Langer R., Weaver J. Electroporation of mammalian skin A mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
30. Pudenz R. Adverse effects of electrical energy applied to the nervous system. Neurosurgery. 1:1977;190-191.
31. Pudenz R., Bullara L., Dru D., Talalla A. Electrical stimulation of the brain. II. Effects on the blood-brain barrier. Surg. Neurol. 4:1975;265-270.
32. Roy S., Horwitz S. Characterization of the association of radiolabeled bleomycin A2 with HeLa cell. Cancer Res. 44:1984;1541-1546.
33. Salford L., Persson B., Brun A., Ceberg C., Kongstad P., Mir L.M. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194:1993;938-943.
34. Sausville E., Peisach J., Horwitz S. A role for ferrous and oxygen in the degradation of DNA by bleomycin. Biochem. Biophys. Res. Commun. 73:1976;814-822.
35. Tsuruo T. Mechanism of multidrug resistance and implication for therapy. Jpn. J. Cancer Res. 79:1988;285-296.
36. Williams P., Henner W., Roman-Goldstein S., Dahlborg S., Brummett R., Tableman M., Dana B., Neuwelt E. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery. 37:1995;17-28.
37. Wolf H., Rols M., Boldt E., Neumann E., Teissie J. Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys. J. 66:1994;524-531.